🇺🇸 Actos (Pioglitazone) in United States

394 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bladder Cancer — 222 reports (56.35%)
  2. Nausea — 32 reports (8.12%)
  3. Blood Glucose Increased — 30 reports (7.61%)
  4. Diarrhoea — 20 reports (5.08%)
  5. Fatigue — 20 reports (5.08%)
  6. Asthenia — 15 reports (3.81%)
  7. Renal Failure — 15 reports (3.81%)
  8. Metastatic Carcinoma Of The Bladder — 14 reports (3.55%)
  9. Blood Glucose Decreased — 13 reports (3.3%)
  10. Headache — 13 reports (3.3%)

Source database →

Actos (Pioglitazone) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Actos (Pioglitazone) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Actos (Pioglitazone) in United States?

Taipei Veterans General Hospital, Taiwan is the originator. The local marketing authorisation holder may differ — check the official source linked above.